Gerbisa L Syrup

The syrup formulation allows for easy administration, particularly in pediatric and geriatric populations who may have difficulty swallowing tablets. Gerbisa L Syrup typically produces a bowel movement within 6 to 12 hours after oral administration. Dosage should be individualized based on patient age and severity of constipation, with careful adherence to recommended guidelines to avoid potential adverse effects such as abdominal cramps, electrolyte imbalance, or dehydration.

It is contraindicated in patients with intestinal obstruction, acute abdominal conditions, or hypersensitivity to the active ingredient. Caution is advised in patients with electrolyte disturbances or renal impairment. Adequate hydration should be maintained during treatment. Gerbisa L Syrup should be used under medical supervision, and prolonged use beyond one week is generally not recommended without consulting a healthcare professional.